BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Medexus to Participate in the 2023 Bloom Burton & Co. Healthcare Investor Conference

  Medexus Pharmaceuticals is pleased to announce that company management will be participating in the 2023 Bloom Burton & Co. Healthcare Investor Conference from April 25 to 26, 2023.

  April 18, 2023

   · 

  3 min read
• Drug Development

  AACR 2023 | ImmVira presented preclinical study results of first CAR-T enabler oncolytic product MVR-T7011 at AACR Annual Meeting

  ImmVira presented preclinical study results of CAR-T enabler oHSV product MVR-7011 through poster publication at the American Association for Cancer Research annual meeting.

  April 18, 2023

   · 

  2 min read
• Biotech Bay

  ExThera Medical Successfully Completes Phase I of PURIFY RCT: US Investigational Device Exemption Trial Evaluating Seraph 100 for the Treatment of Septic Shock

  Investigators today announced completion of patient enrollment in the pharmacokinetic/pharmacodynamic phase of the PURIFY Randomized Clinical Trial (RCT), as required by the US Food Drug Administration.

  April 18, 2023

   · 

  4 min read
• Cipher Pharmaceuticals to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference

  Cipher Pharmaceuticals (TSX: CPH), a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products, will be participating in the 2023 Bloom Burton & Co. Healthcare Investor

  April 18, 2023

   · 

  2 min read
• Genetown

  Gamida Cell Announces Launch of Public Offering of Securities - April 19, 2023

  Gamida Cell Ltd. announced the launch of a follow-on public offering of its ordinary shares and accompanying warrants to purchase its ordinary shares.

  April 18, 2023

   · 

  3 min read
• Drug Development

  Cali Biosciences Initiates Phase III Studies of CPL-01 (Long-Acting Ropivacaine) to Decrease Post-Operative Pain and Reduce or Eliminate Opioid Use

  Cali Biosciences Co., Ltd. announced it has initiated Phase III studies of its core product, CPL-01, with dosing in hernia patients already begun and dosing in bunion patients scheduled to start next month.

  April 18, 2023

   · 

  3 min read
• Cosmetic Bioactive Ingredients Market Growth 5.4% CAGR to 2028 Dominated by Amino Acids held Market Share of 20.81% in 2021 – The Insight Partners

  The Insight Partners published latest research report on “Cosmetic Bioactive Ingredients Market Growth Report, Size, Share Forecast to 2028 - COVID-19 Impact and Global Analysis By Ingredient Type, Sources and Geography,”

  April 18, 2023

   · 

  8 min read
• BioMidwest

  PharmaJet Announces U.S. Government Award Expansion to Clinically Assess a DNA Vaccine Combined with its Systems

  PharmaJet® announced that it received a scope expansion and 3-year extension of its multi-year agreement with the Joint Science and Technology Office of the U.S. Defense Threat Reduction Agency.

  April 18, 2023

   · 

  3 min read
• Research Shows Long Read Sequencing Market is Rising at 22.3% CAGR by 2028

  The Insight Partners published latest research report on “Long Read Sequencing Market Trends Report, Size, Share, Growth Rate Forecast to 2028 - COVID-19 Impact and Global Analysis By Technology, Product, Application, End User and Geography,”

  April 18, 2023

   · 

  8 min read
• Policy

  Grifols 2022 Annual Report on Form 20-F filed with the SEC on April 18, 2023

  Grifols, S.A. announces the filling of its Annual Report on Form 20-F for the fiscal year ended December 31, 2022, with the United States Securities and Exchange Commission.

  April 18, 2023

   · 

  5 min read